Online Inquiry
MAP2K1 (-/-) Cell Line
SPL-01956
| Size | Price |
| 1 Unit | Online Inquiry |
| Description |
|---|
| MAP2K1 (-/-) |
| Target Information | |
|---|---|
| Target Name | MEK1 |
| Gene Abbr. | MAP2K1 |
| Gene ID | 5604 |
| Full Name | mitogen-activated protein kinase kinase 1 |
| Alias | CFC3, MAPKK1, MEK1, MEL, MKK1 |
| Species | Human |
| Genomic Locus | 15q22.1-q22.33 |
| Introduction | The protein encoded by this gene is a member of the dual specificity protein kinase family, which acts as a mitogen-activated protein (MAP) kinase kinase. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals. This protein kinase lies upstream of MAP kinases and stimulates the enzymatic activity of MAP kinases upon wide variety of extra- and intracellular signals. As an essential component of MAP kinase signal transduction pathway, this kinase is involved in many cellular processes such as proliferation, differentiation, transcription regulation and development. [provided by RefSeq, Jul 2008]. |
| Product Details | |
|---|---|
| Cell Line Model | DLD-1 |
| Genotype | MAP2K1 (-/-) |
| Description | MAP2K1 (-/-) |
| Parental ATCC ID | CCL-221 |
| STR Profile | Amelogenin: X,Y; CSF1PO: 11,12; D13S317: 8,11; D16S539: 12,13; D5S818: 13; D7S820: 10,12; THO1: 7,9.3; TPOX: 8,11; vWA: 18,19; ATCC |
| Disease | Colorectal adenocarcinoma, Dukes Type C |
| Tissue | Colon |
| Gender | Male |
| Key Endogenous Mutations | APC, BRCA2, FAM123B, KRAS, MSH6, PI3KA, TP53, |
| CVT Selection Condition | G418 resistant - 0.4 mg/mL |
| Cell Number | 1x10^6 |
| Handling Specifications | |
|---|---|
| Revival | Cells are cultured as a monolayer at 37°C in a humidified atmosphere with 5% CO2. Cells should be passaged every 3-5 days. Split at 70-80% confluency, approximately 1:6-1:10. |
| Culture Medium | RPMI 1640 including 2 mM L-glutamine and 25 mM sodium bicarbonate, supplemented with 10% FBS. |
| Growth Properties | Cells are cultured as a monolayer at 37°C in a humidified atmosphere with 5% CO2. Cells should be passaged every 3-5 days. Split at 70-80% confluency, approximately 1:6-1:10. |
| Freeze Medium | Complete growth media 45% + USDA approved FBS 50% + DMSO 5% |
| Biosafety Level | BSL-1 |
| Disclaimer | This product is classified under IATA regulations as a GMMO (genetically modified micro-organism) and will ship as UN3245. If applicable, ensure facility meets all requirements per local and country regulations. |
For research use only. Not intended for any clinical use. No products from CD BioSciences may be resold, modified for resale or used to manufacture commercial products without prior written approval from CD BioSciences.